መነሻ › የጉበት ካንሰር (ሄፓቶሴሉላር ካርሲኖማ) › Pennsylvania › Pittsburgh
በPittsburgh፣ PA ለየጉበት ካንሰር (ሄፓቶሴሉላር ካርሲኖማ) የሚደረጉ ክሊኒካዊ ጥናቶች
ለየጉበት ካንሰር (ሄፓቶሴሉላር ካርሲኖማ) የሚደረጉ 15 ጥናቶች በPittsburgh እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Phase 1 Study of the Safety and Tolerability of CTX-10726
ተሳታዮችን በመፈለግ ላይደረጃ 1
- UPMC Hillman Cancer Center, Pittsburgh
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Exelixis Clinical Site #32, Pittsburgh
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Upmc Hillman Cancer Center(Univ of Pittsburgh), Pittsburgh
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Pittsburgh
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
Molecular Basis of Pediatric Liver Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Allegheny General Hospital, Pittsburgh
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UPMC Hillman Cancer Center, Pittsburgh
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Clinical Trial Site, Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UPMC Hillman Cancer Center, Pittsburgh
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UPMC Hillman Cancer Center, Pittsburgh
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UPMC Hillman Cancer Center, Pittsburgh
በሌሎች ከተሞች ለየጉበት ካንሰር (ሄፓቶሴሉላር ካርሲኖማ) የሚደረጉ ጥናቶች
- Houston, TX31 ጥናቶች
- New York City, NY24 ጥናቶች
- Dallas, TX19 ጥናቶች
- Los Angeles, CA19 ጥናቶች
- Boston, MA18 ጥናቶች
- Cleveland, OH18 ጥናቶች
- Chicago, IL16 ጥናቶች
- Philadelphia, PA16 ጥናቶች
- San Francisco, CA14 ጥናቶች
- Orange, CA14 ጥናቶች
- Jacksonville, FL14 ጥናቶች
- San Antonio, TX13 ጥናቶች
በPittsburgh ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር48 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)41 ጥናቶች
- የጡንቻ ካንሰር39 ጥናቶች
- የኮሎሬክታል ካንሰር32 ጥናቶች
- Metastatic Cancer31 ጥናቶች
- ሜላኖማ31 ጥናቶች
- የእንቁላል ካንሰር30 ጥናቶች
- የኤንዶሜትሪየም ካንሰር23 ጥናቶች
- የፕሮስቴት ካንሰር23 ጥናቶች
- የሳንባ ካንሰር23 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ22 ጥናቶች
- ስትሮክ22 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።